Bella Mehta bella_mehta
4 years 10 months ago
There is a lot of talk about #COVID19 vaccines, however we don't much about existing vaccines (eg flu) in our patients! Much more work to be done here in rheumatology! @DrDavidKarp at #ACR21 opening session @rheumnow
Eric Dein ericdeinmd
4 years 10 months ago
@DoctorYasmin: "Let's talk about the history ... let's build bridges." We individualize approach to treatments, we should also individualize our conversation about vaccine hesitancy to your patient's specific concerns. @rheumnow #ACR21 https://t.co/1Jxw8l2phB
David Liew drdavidliew
4 years 10 months ago
@DoctorYasmin @RheumNow Great discussion #ACR21 @DoctorYasmin: how do we stop panic/misinformation during a pandemic?
To improve health literacy, we need to learn how to engage better:
- understand the issues/public thinking
- targeted messaging to different communities
- avoid medical hubris
@RheumNow https://t.co/FLvPvX3UJc
Eric Dein ericdeinmd
4 years 10 months ago
@DrDavidKarp: "We are learning about #COVID19 vaccine, but we don't know what to do about the other vaccines." Its a great opportunity for us to learn, research, and educate about the flu, shingles, pneumonia, and more vaccines. 💉 @RheumNow #ACR21
Md Yuzaiful Md Yusof Yuz6Yusof
4 years 10 months ago
"I am often asked when are we going back to normal? NO! I don't want to go back to Normal....we need systems that are more resilient" @DoctorYasmin on lessons learned from #COVID to prepare for future challenges/outbreaks #ACR21 @RheumNow https://t.co/DAdCH80uQ5
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 10 months ago
@DoctorYasmin notes that anti-vaccination is not a new phenomenon & that we cannot adopt a "one size fits all" method in tackling vaccine hesitancy. She emphasizes the need for targeted messaging & the ideology that vaccination is anti-American must be debunked! #ACR21 @RheumNow https://t.co/cU33XEOYhM
David Liew drdavidliew
4 years 10 months ago
"If we go back to business as usual, we will have failed." @DoctorYasmin in the #ACR21 Opening Session.
We need systems that don't need a crisis to shine on them to progressively change for the better. @RheumNow https://t.co/uf4OO2VpHV
Dr. John Cush RheumNow
4 years 10 months ago
RheumNow’s expanded coverage of the #ACR21 annual meeting is sponsored in part by @Novartis. All content chosen by #RheumNow & its Faculty.
Meral K. El Ramahi, MD MeralElRamahiMD
4 years 10 months ago
So excited to cover the annual #ACR21 Convergence Conference aside the amazing @Rheumnow Faculty team. A hearty congratulations to our wonderful leader, Dr. Jack Cush @RheumNowNews, for the well-earned designation as an ACR Master. https://t.co/v6fAyqH1CU
David Liew drdavidliew
4 years 10 months ago
Congratulations to all the ACR Masters announced in the #ACR21 Opening Session, particularly @RheumNow's Jack Cush.
It's been such a privilege learning from you. Amongst all you've done, thank you for opening up the global rheumatology discussion like never before. True impact! https://t.co/MMh8owLfY6
CreakyJoints will present 11 posters and two oral presentations at ACR 2021. COVID-19 research revealed significantly high levels of anxiety, anger, depression, and social isolation, which were linked to medication interruptions and associated flares suggesting during the pandemic, patients often felt unsupported by all levels of the healthcare system.
The pharmaceutical companies will feature the results of their pivotal clinical trials and data analyses at ACR Convergence 2021. Below is a listing of some of their best studies for you to review and look for in the meeting. Often these become the pivotal studies for regulatory approval and the annual congresses are their first look.
Bristol Myers Squibb
Dr. John Cush RheumNow
4 years 10 months ago
Intensive RA Rx in the TITRATE study showed Disease activity & less remission in in obese patients, but Anxiety, depression and health perceptions were associated with higher pain and fatigue scores. These are unaccounted for in Rx strategies https://t.co/B8izEjfz8P
Dr. John Cush RheumNow
4 years 10 months ago
How I Treat Rheumatoid Arthritis
My Stepwise Approach to DMARD, Biologic and Targeted Synthetic Use in RA patients
QD Clinic is sponsored by https://t.co/V10S4oVFsv's coverage of #ACR21 (November 5-9, 2021)
https://t.co/jizbQ0Bgxq https://t.co/fXLheKv5dw
Dr. John Cush RheumNow
4 years 10 months ago
Treat-to-Target Works in Gout With No Cardiac Toxicity
New research presented this week at ACR Convergence shows that allopurinol and febuxostat may effectively lower urate levels when used in a treat-to-target approach. #ARC21
Read more...
https://t.co/r2usSxNnfZ https://t.co/GIgAP3T2hd
